In glucocorticoid target organs, local concentrations of active glucocorticoid are determined by the relative expression of two 11 -hydroxysteroid dehydrogenases (HSDs): bi-directional 11 -HSD type1 (11HSD1) that mainly activates cortisone to cortisol, and dehydrogenase 11 -HSD type2 (11HSD2) that inactivates cortisol to cortisone. In this study, we examined the expression of mRNA encoding these two 11 -HSDs in bovine granulosa cells harvested from preovulatory follicles and corpora lutea (CL). Ovaries were obtained from Holstein cows at a local slaughterhouse. Follicles larger than 10 mm in diameter and CL were dissected and follicular fluid and granulosa cells were taken. Corpora lutea were weighed and their stages were morphologically assessed (stage I, days 1-4; stage II, days 5-10; stage III, days 11-17; stage IV, days 8-20). Follicles were classified into four groups according to their hormonal status (oestradiol (E 2 ): progesterone (P 4 )>1: oestrogen active; E 2 :P 4 <1: oestrogen inactive) and stage of the oestrous cycle (luteal or follicular phase). Total RNA was extracted with phenol-chloroform and subjected to a semi-quantitative RT-PCR for 11HSD1, 11HSD2 and -actin. Concentrations of steroids in follicular fluid were determined by an enzyme immunoassay. In granulosa cells, only 11HSD1 mRNA was detected. There was a negative correlation between the expression of 11HSD1 and the concentration of cortisol in follicular fluid (P<0·05), indicating 11HSD1 may act as a dehydrogenase in the bovine follicle. Both types of 11 -HSDs were expressed in CL. The levels of mRNA for both isozymes were high in stage I and II, and were decreased in stage III CL. In stage IV CL, the expression of 11HSD2 but not 11HSD1 mRNA increased. These results indicate that the bovine granulosa cells and CL express 11HSD1 and 11HSD2, and they may play an important physiological role in the bovine ovary through modulating the local glucocorticoid environment.
Introduction
The ovary expresses glucocorticoid receptor (GR) and direct action of glucocorticoid on various ovarian functions has been reported in several species (Hsueh & Erickson 1978 , Luck 1988 , Fitzpatrick & Richards 1991 , Kawate et al. 1993 , Urban et al. 1994 , Spicer & Chamberlain 1998 , Gaytan et al. 2002 , Yang et al. 2002 . The ovary does not produce glucocorticoid per se and the access of active glucocorticoid (i.e. cortisol) to GR is regulated by the relative expression of two 11 -hydroxysteroid dehydrogenases (HSDs): a bi-directional 11 -HSD type 1 (11HSD1) that mainly activates cortisone to cortisol (11-dehydrocorticosterone to corticosterone in rodents), and a dehydrogenase 11 -HSD type 2 (11HSD2) that inactivates cortisol to cortisone (Krozowski et al. 1999) . Recently, it was shown that the expression of 11HSD1 is dramatically up-regulated while that of 11HSD2 is down-regulated in human and rat follicles during human chorionic gonadotrophin-induced ovulation (Tetsuka et al. 1997 (Tetsuka et al. , 1999 . In humans, this change in expression results in a temporal rise in cortisol in follicular fluid (Harlow et al. 1997) . The physiological importance of this phenomenon is not clear. It is suggested, however, that the increased level of cortisol may enhance oocyte maturation (Fateh et al. 1989 , Michael et al. 1999 or suppress inflammation associated with ovulation, thereby promoting rapid healing of the wound left by follicular rupture (Hillier & Tetsuka 1998) . In pregnant rat corpora lutea (CL), the expression of 11HSD2 was shown to be dramatically up-regulated, which was coincident with the rise in circulating glucocorticoid just prior to parturition (Waddell et al. 1996) . Regarding an anti-luteolytic nature of glucocorticoid, the expression of 11HSD2 appears to be important for prepartal luteal regression, which is a prerequisite for parturition (Waddell et al. 1996) . Thus, these results indicate that the magnitude of glucocorticoid action in the ovary is mainly determined by the relative expression of these two 11 -HSDs in these species.
In cattle, glucocorticoid is both stimulatory and inhibitory to ovarian functions. It has been shown to enhance progesterone (P 4 ) (Kawate et al. 1993 ) and oxytocin production (Luck 1988) in cultured granulosa cells, and insulin-like growth factor-stimulated P 4 and androstenedione production in cultured thecal cells (Spicer & Chamberlain 1998) , whereas it was shown to inhibit production of oestradiol-17 (E 2 ) and expression of luteinising hormone (LH)-receptor in cultured granulosa cells (Kawate et al. 1993) . For healthy follicular development, therefore, it is necessary that the expression of these factors is properly regulated in the face of circulating glucocorticoid.
We hypothesized that 11HSD is present in bovine preovulatory follicles and CL and may play an important role in promoting follicular maturation and maintaining CL functions through attenuating local levels of glucocorticoid. In this study, we tested this hypothesis by examining the expression of mRNA encoding 11HSD1 and 11HSD2 in bovine granulosa cells harvested from preovulatory follicles and CL of various physiological stages.
Materials and Methods

Collection of tissue samples
Ovaries were obtained from Holstein cows at a local slaughterhouse. The ovaries were kept in pairs in ice-cold PBS and brought to the laboratory within one hour after slaughter. Follicles larger than 10 mm in diameter and CL were dissected from the ovaries. Follicular fluid was aspirated from each follicle, centrifuged briefly at 800 g to remove follicular debris and kept at 20 C until steroid hormone assays. Granulosa cells were harvested by gently scraping the follicular wall with a spatula and centrifuging briefly at 800 g. The resultant pellet was lysed in ice-cold denaturing solution containing 4 M guanidium thiocyanate (Wako Pure Chemical Industries Ltd, Osaka, Japan), 25 mM sodium citrate (Wako), 0·5% (w:v) sarcosyl (Sigma Chemical Co., St Louis, MO, USA), and 0·1 M -mercaptoethanol (Kanto Chemical Co. Inc, Tokyo, Japan). The remaining follicular wall was washed with PBS to remove as many of the granulosa cells as possible and this served as thecal tissue. Corpora lutea were weighed and were then morphologically assessed and assigned to one of four categories (stage I, days 1-4; stage II, days 5-10; stage III, days [11] [12] [13] [14] [15] [16] [17] stage IV, according to the method of Ireland et al. (1980) . They were sliced into small pieces and frozen in liquid nitrogen. The follicles were classified into four groups according to their hormonal status (E 2 :P 4 >1, oestrogen active; E 2 :P 4 <1, oestrogen inactive) and the stage of the oestrous cycle estimated by the status of the accompanying CL (luteal phase, stages I-III or follicular phase, stage IV). Under these criteria, oestrogen active (EA) follicles are preovulatory follicles destined for ovulation (follicular phase) or non-ovulatory dominant follicles (luteal phase), while oestrogen inactive (EI) follicles in both phases are either subordinate follicles destined for atresia or dominant follicles from the previous follicular wave in static or regressing phase. In total, 36 preovulatory follicles from 28 cows were used in the present study.
Uterine carunculer and inter-carunculer tissues were also obtained from a non-pregnant Holstein cow at the slaughterhouse. Other tissue samples, including the liver, kidney, adrenal and spleen were obtained from a Holstein steer killed at the university farm. Leukocytes were obtained from pooled blood samples collected from cyclic non-pregnant cows.
RNA isolation and reverse transcription-polymerase chain reaction (RT-PCR)
Tissue samples were homogenized in the denaturing solution. Total RNA was extracted from granulosa cell lysates and tissue homogenates with phenol-chloroform (Chomczynski & Sacchi 1987) . The resultant total RNA was further purified and DNase treated using an SV total RNA extraction kit (Promega Co., Madison, WI, USA). The total RNA was quantified and its purity assessed by spectrophotometry. The integrity of the RNA was confirmed by gel electrophoresis to visualize 28S and 18S rRNA. While the RNA samples obtained from granulosa cells were exclusively granulosa in origin, those from CL were a mixture of RNAs from luteal and endothelial cells together with a small amount of blood cells.
Single-strand cDNA was reverse transcribed from total RNA (0·5 µg) using MMLV-reverse transcriptase (Promega) and an oligo dT primer (Promega) at 37 C for 60 min. One-twentieth of the resultant cDNA was used for PCR amplifications (26 cycles for actin, 30 cycles for 11 -HSDs) using Taq-DNA polymerase (Promega) in a 20 µl reaction. Each PCR cycle consisted of 45 s denaturing at 94 C, 45 s annealing at 55 C (actin) or 60 C (11 -HSDs), and 60 s extension at 72 C with the final extension for 10 min. A set of serially diluted total RNA from the liver (11 HSD1: 2500 ng), adrenal gland (11HSD2: 2500 ng) or CL (actin: 82000 ng) was included in each RT-PCR trial to construct a standard curve. The primers for 11 -HSDs and -actin were designed using an online primer design tool, Primer 3 (Rozen & Skaletsky 2000: http://www-genome.wi. mit.edu/cgi-bin/primer/primer3_www.cgi) based on the bovine sequences for 11HSD2 and -actin and the ovine sequence for 11HSD1 (Table 1 ). The amplified DNA was resolved on 2% agarose gel containing ethidium bromide and visualized under UV illumination. Signal intensities were analysed by computerized densitometry (Luminous Imager version 2·0 G, Aisin Cosmos RD Co. Ltd, Aichi, Japan) and relative abundance of the target mRNA was estimated using the standard curve. The values were normalized using -actin as an internal standard. A second set of the RNA samples was subjected to amplifications without the reverse transcriptase to monitor possible contamination of the RNA samples with genomic DNA. No signal was detected in these amplifications. The PCR products were either sequenced (11HSD1: GenBank accession no. AF548027) or cut by restriction enzymes (11HSD2 and -actin) and their authenticity was confirmed. The sequenced bovine 11HSD1 cDNA fragment is 554 bp in length and shares 96%, 77% and 63% sequence identity with sheep (P51975), human (XP005516) and rat (NP 058776) 11HSD1 respectively.
Steroid hormone assay
Concentrations of P 4 , E 2 and cortisol in the follicular fluid samples were determined by an enzyme immunoassay (EIA) as mentioned previously (Miyamoto et al. 1992 , Wijayagunawardane et al. 1998 , Acosta et al. 2002 .
The range of the standard curve and the ED 50 of the assay were 0·8-80 ng/ml and 2·5 ng/ml for cortisol, 2-2000 pg/ml and 110 pg/ml for E 2 and 0·05-25 ng/ml and 2·4 ng/ml for P 4 respectively. The intra-and interassay coefficients of variation were 6·8 and 8·6% for cortisol, 4·8 and 7·5% for P 4 , and 6·3 and 8·5% for E 2 respectively. The cross-reactivities of the cortisol antibody were 100% for cortisol, 11·5% for 11-deoxycortisol, 4% for cortisone, 2% for corticosterone, 0·035% for P 4 , 0·06% for androstenedione, 0·02% for testosterone, and less than 0·01% for aldosterone, pregnenolone, dehydroepiandrosterone and E 2 (Acosta et al. 2002) .
Statistical analysis
Data were transformed to logarithms before analysis when necessary. The effects of hormonal status (EA vs EI) and phase of the oestrous cycle (follicular vs luteal) on the expression of 11HSD1 in granulosa cells and the levels of cortisol in follicular fluid were analysed using a two-way analysis of variance (ANOVA). Comparisons among group means were carried out using a one-way ANOVA, followed by a Tukey-Kramer test. The relationships between the levels of 11HSD1 expression and follicular cortisol, and between levels of 11HSD1 and 11HSD2 mRNA in CL were analysed by regression analysis.
Results
The expression of 11HSD1 mRNA was detected in the liver, kidney, spleen, CL, granulosa cells, thecal, uterine caruncle and inter-carunculer tissues with a weak signal detected in the adrenal, whereas 11HSD2 mRNA was detected in the kidney, adrenal, CL and uterine tissues with a weak signal also detected in the spleen (Fig. 1) . The expression of 11HSD1 mRNA in the CL, granulosa cells and thecal tissue was approximately 20, 10 and 5% of that in the liver respectively, while the expression of 11HSD2 mRNA in the CL was approximately 10% of that in the kidney.
Only 11HSD1 mRNA was detected in granulosa cells while both 11HSD1 and 11HSD2 were detected in CL (Fig. 2) . The expression of 11HSD1 mRNA in stage II CL (84·4 35·5, mean S.E.M arbitrary units, n=5) was significantly higher than that in granulosa cells harvested from EA follicles in the follicular phase (8·6 6·0, mean S.E.M arbitrary units, n=8, P<0·01).
The expression of 11HSD1 mRNA varied among follicles of different hormonal status (Fig. 3a) . The ANOVA revealed a significant phase effect on the expression of 11HSD1 mRNA (P<0·01), while no status effect was found. A significant interaction between the phase and status of follicles was also found (P<0·01). There were significant differences in levels of 11HSD1 mRNA between the luteal phase EI and the luteal phase EA, and the luteal phase EI and the follicular phase EI (P<0·05). Cortisol was detected in follicular fluid from all follicles. There was no significant phase or status effect on the levels of follicular cortisol (Fig. 3b) . In all four groups, the levels of cortisol tended to decrease as the levels of 11HSD1 mRNA increased, although the correlation between these two indices did not reach a significant level except for luteal phase EA: follicular phase EA (R 2 =0·32, P=0·14, n=8), follicular phase EI (R 2 =0·49, P=0·12, n=6), luteal phase EA (R 2 =0·34, P<0·05, n=13), luteal phase EI (R 2 =0·32, P=0·11, n=9). When all data were combined, a significant negative correlation was found between the levels of 11HSD1 mRNA and cortisol (R 2 =0·18, P<0·05, n=36) (Fig. 4) .
The levels of mRNA for 11HSD1 and 11HSD2 decreased in stage III CL compared with those in stages I and II (P<0·05 and P<0·01 for 11HSD1 and 11HSD2 respectively) (Fig. 5a ). While the expression of 11HSD1 mRNA continued to decrease, the expression of 11HSD2 rebounded in stage IV CL and was significantly higher than that in stage III CL (P<0·01) (Fig. 5a ). When all data were combined, a significant positive correlation was found between levels of 11HSD1 and 11HSD2 mRNA (R 2 =0·42, P<0·01, n=20) (Fig. 5b) .
Discussion
In this study we have shown that (1) the bovine ovarian tissues express 11 -HSD mRNA at a level comparable with that in classic glucocorticoid target organs such as the liver, (2) preovulatory follicles only express 11HSD1 while CL express both 11HSD1 and 11HSD2 mRNA, (3) in preovulatory follicles, 11HSD1 may decrease local concentrations of cortisol, and (4) in CL the expression of 11HSD1 and 11HSD2 fluctuates during luteal development and regression. Because glucocorticoid is only synthesized in the adrenal cortex and is delivered systemically to the whole body, the presence of 11 -HSD is crucial for glucocorticoid target organs such as the liver and lung for modulating local concentrations of active glucocorticoid (Krozowski et al. 1999) . The expression of 11HSD1 and 11HSD2 in bovine ovarian tissues, together with the reported direct glucocorticoid action in cultured follicular cells (Luck 1988 , Kawate et al. 1993 , Spicer & Chamberlain 1998 , indicates that the bovine ovary is a glucocorticoid target organ which is also capable of modulating the local glucocorticoid environment.
Because the circulating levels of cortisol are largely unchanged throughout the bovine oestrous cycle (Garverick et al. 1971 , Roussel et al. 1983 , Lyimo et al. 2000 , this system may play an important role in regulating ovarian glucocorticoid action.
In humans, the relative expression of 11HSD1 and 11HSD2 has been shown to determine levels of cortisol in Figure 1 Detection of 11 -HSD type 1 (11HSD1) and type 2 (11HSD2) mRNAs in various organs by RT-PCR. The levels of 11HSD1 and 11HSD2 mRNA were quantified by a semi-quantitative RT-PCR using actin as an internal standard. A 598 bp band for 11HSD1 was detected in the liver (Lv, 100%), kidney (Kd, 3% of the liver), adrenal (Ad, 1%), spleen (Sp, 2%), CL (18%), granulosa cells (GC, 12%), thecal tissue (TC, 5%), uterine caruncle (UC, 6%) and inter-carunculer (UI, 3%) tissues, whereas a 707 bp band for 11HSD2 was detected in the Kd (100%), Ad (84% of the kidney), Sp (1%), CL (11%), UC (22%) and UI (35%) with a weak signal also detected in the Sp (1%). No signal was detected in leukocytes (Lc). GC and TC were harvested from a preovulatory oestrogen active follicle (>10 mm) in the follicular phase, while the CL sample was collected from a stage II CL. follicles (Yong et al. 2001) . In maturing preovulatory follicles before the mid-cycle surge of gonadotrophins, the expression of 11HSD2 dominates over that of 11HSD1, resulting in lower levels of cortisol in the follicular fluid compared with that in the serum (Yding Andersen et al. 1999 ). This mechanism is likely to be beneficial for maturing follicles, as active glucocorticoids have been shown to inhibit oestrogen production in cultured granulosa cells (Hsueh & Erickson 1978 , Kawate et al. 1993 .
The preovulatory gonadotrophin surge dramatically induces the expression of 11HSD1 while it decreases the expression of 11HSD2 in follicles (Tetsuka et al. 1997 , Yong et al. 2001 . This results in a rapid increase in follicular cortisol just before follicular rupture (Harlow et al. 1997) . The physiological importance of this event is not clear but it may enhance oocyte maturation (Fateh et al. 1989 , Michael et al. 1999 or prevent excess inflammation caused by ovulation (Hillier & Tetsuka 1998) . In the present study, however, all follicles were collected before the gonadotrophin surge and thus the presence of a similar mechanism in the bovine preovulatory follicles is still to be clarified.
Interestingly, the bovine preovulatory follicles were shown to express 11HSD1 only. This is different from the results found in human and rat follicles where 11HSD2 is a predominant 11 -HSD before the preovulatory gonadotrophin surge (Tetsuka et al. 1997 (Tetsuka et al. , 1999 . The expression of follicular 11HSD1 was found to be highest in luteal phase EI follicles. The mechanism that regulates 11HSD1 expression is not clear. Nevertheless, follicles of all categories expressed comparable levels of 11HSD1, indicating that the enzyme expression is not much affected by the physiological status of the follicles. The concentrations of cortisol in follicular fluid found in this study are in accord with those reported in bovine follicular fluid (Spicer & Zinn 1987) . In the present study, however, a significant negative correlation was found between levels of 11HSD1 mRNA and follicular cortisol. This result implies that 11HSD1 may act as a dehydrogenase rather than as a reductase. In human and rodents, the 11HSD1 is known to be a bi-directional enzyme with a predominant reductase activity (Krozowski et al. 1999) . In ovine placenta, on the other hand, it was shown that 11HSD1 acts predominantly as a dehydrogenase and protects a fetus from adverse effects of maternal glucocorticoid (Yang et al. 1997). Because the bovine 11HSD1 shares a high sequence identity with that of sheep, the bovine isozyme could also, predominantly, be a dehydrogenase. If this is the case, the expression of 11HSD1 may create a favourable environment for increasing oestrogen production by decreasing levels of cortisol which has been shown to inhibit oestrogen production and LH-receptor expression in cultured bovine granulosa cells (Kawate et al. 1993) . Otherwise, this phenomenon might be attributable to the activity of a third 11 -HSD isozyme (11 -HSD type3), a dehydrogenase, the presence of which was implicated in the sheep kidney (Gomez-Sanchez et al. 1997) . Nevertheless, a further study is necessary to characterize bovine 11HSD1. In the bovine CL, both 11HSD1 and 11HSD2 were detected, and their expression levels were much higher than those in the granulosa cells. The expression of both isozymes was high in the developing CL (stages I and II) and decreased in stage III CL, in which progesterone production reaches a maximum level. The expression of these two isozymes appeared to be similarly regulated except in the regressing CL (stage IV) where 11HSD2 rebounds while 11HSD1 remains low. These results indicate that a local glucocorticoid environment is regulated in a stage-specific manner in the bovine CL. It is reported that the bovine CL produces prostaglandins and that they act as important local regulators of CL functions (Milvae 1986 , Kobayashi & Miyamoto 2000 . Administration of an inhibitor of prostaglandin synthesis, indomethacin, has been shown to inhibit CL development if given early in the oestrous cycle (Milvae 1986 ). On the other hand, indomethacin given later in the oestrous cycle resulted in an extended CL life span (Milvae 1986) . Repeated administrations of a synthetic glucocorticoid, betamethasone, during the luteal phase have also been shown to prolong luteal life span in cattle (Kanchev et al. 1976 , Dobson et al. 1987 . Although these effects are likely to be due to the inhibitory action of these agents on prostaglandin F 2 synthesis by the uterine endometrium or/and on pituitary function (Dobson et al. 1987) , it is possible that glucocorticoid also acts directly to modulate CL function. Glucocorticoid inhibits prostaglandin synthesis in rat ovary (Kol et al. 1998) , and inactivation of glucocorticoid by 11HSD2 appears to be necessary for the regression of CL in the pregnant rat just prior to parturition (Waddell et al. 1996) . Taken together, these reports suggest that cortisol may inhibit CL development and regression directly. The expression of 11 -HSDs observed in the present study, therefore, may be part of the regulatory system that facilitates CL formation and regression through protecting local prostaglandin synthesis from circulating cortisol.
The expression of 11 -HSDs, especially that of 11HSD2, was low in stage III CL. The down-regulation of 11HSD2 might be due to high levels of P 4 produced by the CL. It is reported that P 4 decreased 11HSD2 bioactivity in cultured human placenta (Sun et al. 1998) . High levels of P 4 may also increase local concentrations of free cortisol by displacing it from its binding proteins (Andersen 2002) . If similar regulations are operating in bovine CL, the high levels of P 4 may create a favourable environment for cortisol action in stage III CL. It is also possible that cortisol, in turn, increases P 4 production (Hsueh & Erickson 1978 , Kawate et al. 1993 .
In summary, the bovine follicle and CL express 11 -HSD isoforms. The expression of 11HSD1 and 11HSD2 is tissue-and stage-specific: the preovulatory follicle before 
